Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
6.50
-0.28 (-4.13%)
At close: Oct 10, 2025, 4:00 PM EDT
6.20
-0.30 (-4.62%)
After-hours: Oct 10, 2025, 7:55 PM EDT
Relay Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts that cover Relay Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $17.25, which forecasts a 165.38% increase in the stock price over the next year. The lowest target is $10 and the highest is $23.
Price Target: $17.25 (+165.38%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 4, 2025.
Analyst Ratings
The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 8 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 12 | 13 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +130.77% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +115.38% | Aug 26, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $29 → $19 | Strong Buy | Maintains | $29 → $19 | +192.31% | Aug 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $30 → $10 | Strong Buy | Maintains | $30 → $10 | +53.85% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +146.15% | Mar 7, 2025 |
Financial Forecast
Revenue This Year
12.74M
from 10.01M
Increased by 27.33%
Revenue Next Year
13.69M
from 12.74M
Increased by 7.40%
EPS This Year
-1.75
from -2.36
EPS Next Year
-1.77
from -1.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 40.3M | 42.2M | |||
| Avg | 12.7M | 13.7M | |||
| Low | 7.5M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 302.9% | 231.3% | |||
| Avg | 27.3% | 7.4% | |||
| Low | -24.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.29 | -1.30 | |||
| Avg | -1.75 | -1.77 | |||
| Low | -2.10 | -2.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.